Effects of sickle cell trait and hemoglobin C trait on determinations of HbA(1c) by an immunoassay method

Diabetes Care

Volumn 21, Issue 6, 1998, Pages 983-986

  Roberts, William L ^a   Mccraw, Mary ^a   Cook, Curtiss B ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HEMOGLOBIN C;

ANALYTIC METHOD; ARTICLE; CLINICAL ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; SICKLE CELL TRAIT;

AFRICAN CONTINENTAL ANCESTRY GROUP; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS; HEMOGLOBIN A; HEMOGLOBIN A, GLYCOSYLATED; HEMOGLOBIN C; HEMOGLOBIN, SICKLE; HUMANS; IMMUNOASSAY; PHENOTYPE; REFERENCE VALUES; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS;

EID: 0031738645     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.21.6.983     Document Type: Article

References (12)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J. Med 329:977-986, 1993
2. Goldstein DE, Wiedmeyer H-M, Little RR, Varagas V, Nair SS, Reid J: Relationship between glycohemoglobin (GHB) and mean blood glucose (MBG) in the Diabetes Control and Complications Trial (DCCT) (Abstract). Diabetes 46 (Suppl. 1):8A, 1997
3. NGSP Steering Committee: Implementation of the National Glycohemoglobin Standardization Program (NGSP) [Abstract]. Diabetes 46 (Suppl. 1):151A, 1997
4. Schneider RG, Hightower B, Hosty TS, Ryder H, Tomlin G, Atkins R, Brimhall B, Jones RT: Abnormal hemoglobins in a quarter million people. Blood 48:629-637, 1976
5. Meyer, LM, Adams JG 3rd, Steinberg MH, Miller IE, Stokes N: Screening for sickle cell trait: the Veterans Administration National Sickle Cell Program, Am J Hematol 24:429-432, 1987
6. Weykamp CW, Penders TJ, Muskiet FAJ, van der Slik W: Influence of hemoglobin variants and derivatives on glycohemoglobin determinations, as investigated by 102 laboratories using 16 methods. Clin Chem 39:1717-1723, 1993
7. Weykamp CW, Martina WV, van der Dijs FPL, Penders TJ, van der Slik W, Muskiet FAJ: Hemoglobin S and C: reference values for glycohemoglobin in heterozygous, double heterozygous and homozygous subjects, as established by 13 methods. Clin Chim Acta 231:161-171, 1994
8. Ward KM, Chiasera JM, Roberts WL: Greater variability in glycohemoglobin test results in patient samples with hemoglobin variants: a comparison of four test systems (Abstract). Clin Chem. In press
9. National Committee for Clinical Laboratory Standards: Method comparison and bias estimation using patient samples: tentative guideline. Villanova, PA, NCCLS, 1993 (NCCLS publication EP9-T)
10. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus; Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197, 1997
11. Tegos C, Blume K, Johnson C, Beutler E: Glycosylated minor C, D, and E hemoglobins. BiochemMed 26:121-125, 1981
12. Goujon R, Thivolet C: Glycation of hemoglobin C in the heterozygous state in diabetic patients (Letter). Diabetes Care 17:247, 1994